US HB1730 | 2021-2022 | 117th Congress
Status
Spectrum: Slight Partisan Bill (Democrat 25-16)
Status: Introduced on March 10 2021 - 25% progression, died in committee
Action: 2021-03-10 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 10 2021 - 25% progression, died in committee
Action: 2021-03-10 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to accelerate development of therapies across the spectrum of rare diseases and conditions and facilitate patient access to such therapies, and for other purposes.
Title
Speeding Therapy Access Today Act of 2021
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2021-03-10 | House | Referred to the Subcommittee on Health. |
| 2021-03-10 | House | Referred to the House Committee on Energy and Commerce. |
| 2021-03-10 | House | Introduced in House |
Same As/Similar To
SB670 (Same As) 2021-03-10 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/117th-congress/house-bill/1730/all-info |
| Text | https://www.congress.gov/117/bills/hr1730/BILLS-117hr1730ih.pdf |
